- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, August 28, 2020
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
USA Today spotlighted an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “A Timeline of COVID-19 Developments in 2020,” took a look at how the coronavirus disease 2019 pandemic evolved and progressed in the first half of 2020.
An article by Becker's Hospital Review cited a study published in the August 2020 issue of AJMC®. The study, “Preferences for and Experiences With Pill Appearance Changes: National Surveys of Patients and Pharmacists,” found opportunities to improve patients’ experiences with pill appearance changes through better notification practices and patient education.
A piece by Business 2 Community referenced a study published in the October 2017 issue of AJMC® titled, “Boosting Workplace Wellness Programs With Financial Incentives.” In the study, researchers found that financial incentives created under the Affordable Care Act can help promote employer wellness programs and support preventive services utilization.
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Challenges in GERD Diagnosis and Treatment: The Need for a Multidisciplinary Approach
January 10th 2025A recent review emphasizes the need for personalized treatment strategies and a multidisciplinary approach to effectively manage the various subtypes of gastroesophageal reflux disease (GERD), highlighting the challenges of diagnosis and treatment, particularly in cases with refractory symptoms.
Read More
